negrogesic
Bluelight Crew
I am curious as to ideas or knowledge of carisoprodol psychopharmacology. Even my 1500 page Med-school "Textbook of Psychopharmacology (Schatzberg, Nemeroff, 4th edition-2009)" it makes only passing reference to carbamates and their activity.
My smaller, "Manual of Clinical Psychopharmacology" (Schatzberg,Cole,De Batista-4th edition-2005) does address it, however very superficially. It does not address carisoprodol directly, only its "pro-drug", meprobamate. It states the following:
the same text states:
The first notion is certainly false, yet this manual is CURRENTLY used in clinical practice, and such statements are dangerous in the even of over dose. It is know to be a direct modulator of GABAa receptor sites (did not look at the *ucking structure?), however its activity (carisopridol) is purportedly not reversed using flumazenil, yet is reversed by barb-antagonists (from what I recall, bemigride or maybe megimide, I believe its structure is, simply put, something like fl-ethyl-fl-methylglutarimide or more specificaly 3[?/3]-ethyl-fl-methylglutarimide).
And then the second notion that its anxiolytic properties (meprobamate) are reversed by naloxone. So what, it MOR affinity? Where are the numbers? Its obviously not in the nM range, and I only see "downsteam" opioidergic properties, but I am not a doctor of medicinal chemistry, and QSAR programs pump out all sorts of weird shit.
2D
3D
In any case, anyone who has taken both miltown or pure meprobamate will realize carisopridol is no mere pro-drug, yes a unknown part of its activity can be attributed to its meprobamate metabolite, but again, it is distinctly (subjectively) different. Can someone people elaborate.
I believe it has been show affinity to glycine a1, and god knows what else (Kainate receptors or ligand-gated ion channeled NMDA sites). I have done the receptors but please, enlighten me. Physicians here in the US have a terrible understand about clinical pharm in general, but focus so much on anatomy, over and over. As a soon to be medical doctor, with supposed expertise in the highly competitive specialty of anesthesia (scary thought I know, no plans to practice) I feel dangerously ignorant, but am more concerned about my oblivious classmates. Propofol has made things easier; ive never killed a dog or human as an anesthetist . I do not have a PhD, but I feel like I should have or need to obtain one or more to be truly informed. Don't even get me started on tramadol, but at least there is better data despite being relatively new compound.
There is endless of info on the pharmacokinetics of carisoprodol, but no consensus on they dynamics/mechanism.
I know there are highly educated and intelligent people who view this forum, please elucidate and enlighten me.
My smaller, "Manual of Clinical Psychopharmacology" (Schatzberg,Cole,De Batista-4th edition-2005) does address it, however very superficially. It does not address carisoprodol directly, only its "pro-drug", meprobamate. It states the following:
Meprobamate does not affect benzodiazepine or GABA receptors. It seems to act by potentiating the action of endogenously released adenosine; it blocks reuptake of adenosine......
the same text states:
Its [meprobamate] antianxiety effects in laboratory animals can be blocked by naloxone
The first notion is certainly false, yet this manual is CURRENTLY used in clinical practice, and such statements are dangerous in the even of over dose. It is know to be a direct modulator of GABAa receptor sites (did not look at the *ucking structure?), however its activity (carisopridol) is purportedly not reversed using flumazenil, yet is reversed by barb-antagonists (from what I recall, bemigride or maybe megimide, I believe its structure is, simply put, something like fl-ethyl-fl-methylglutarimide or more specificaly 3[?/3]-ethyl-fl-methylglutarimide).
And then the second notion that its anxiolytic properties (meprobamate) are reversed by naloxone. So what, it MOR affinity? Where are the numbers? Its obviously not in the nM range, and I only see "downsteam" opioidergic properties, but I am not a doctor of medicinal chemistry, and QSAR programs pump out all sorts of weird shit.
2D
3D
In any case, anyone who has taken both miltown or pure meprobamate will realize carisopridol is no mere pro-drug, yes a unknown part of its activity can be attributed to its meprobamate metabolite, but again, it is distinctly (subjectively) different. Can someone people elaborate.
I believe it has been show affinity to glycine a1, and god knows what else (Kainate receptors or ligand-gated ion channeled NMDA sites). I have done the receptors but please, enlighten me. Physicians here in the US have a terrible understand about clinical pharm in general, but focus so much on anatomy, over and over. As a soon to be medical doctor, with supposed expertise in the highly competitive specialty of anesthesia (scary thought I know, no plans to practice) I feel dangerously ignorant, but am more concerned about my oblivious classmates. Propofol has made things easier; ive never killed a dog or human as an anesthetist . I do not have a PhD, but I feel like I should have or need to obtain one or more to be truly informed. Don't even get me started on tramadol, but at least there is better data despite being relatively new compound.
There is endless of info on the pharmacokinetics of carisoprodol, but no consensus on they dynamics/mechanism.
I know there are highly educated and intelligent people who view this forum, please elucidate and enlighten me.
